CD14 and coronary artery disorder: The mean DNA methylation of all the four CG sites in the TLR4 promoter was significantly reduced in both the CD14+ monocytes from CAD patients (Fig. 5c) and the LDL-treated CD14+ monocytes (Fig. 5d).